Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+ MYPT1 Expression

Open Access

Peer-reviewed

Research Article

Erhan Ararat,

Affiliation Division of Cardiovascular Diseases, Mayo Medical School, Rochester, Minnesota, United States of America
⨯
Frank V. Brozovich

* E-mail: brozovich.frank@mayo.edu

Affiliation Division of Cardiovascular Diseases, Mayo Medical School, Rochester, Minnesota, United States of America
⨯

Reader Comments (0)

MAPK signaling cascades
Is the Subject Area "MAPK signaling cascades" applicable to this article?

Thanks for your feedback.
ACE inhibitor therapy
Is the Subject Area "ACE inhibitor therapy" applicable to this article?

Thanks for your feedback.
Smooth muscles
Is the Subject Area "Smooth muscles" applicable to this article?

Thanks for your feedback.
Heart failure
Is the Subject Area "Heart failure" applicable to this article?

Thanks for your feedback.
Phosphatases
Is the Subject Area "Phosphatases" applicable to this article?

Thanks for your feedback.
Nitric oxide
Is the Subject Area "Nitric oxide" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.